Export 31 results:
Author [ Title(Desc)] Type Year
Filters: Author is Bernstein, David I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
S. S. El-Kamary, Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R., Richardson, C., Bargatze, R. F., Sztein, M. B., and Tacket, C. O., “Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.”, J Infect Dis, vol. 202, no. 11, pp. 1649-58, 2010.
L. E. Widdice, Unger, E. R., Panicker, G., Hoagland, R., S Callahan, T., Jackson, L. A., Berry, A. A., Kotloff, K., Frey, S. E., Harrison, C. J., Pahud, B. A., Edwards, K. M., Mulligan, M. J., Sudman, J., and Bernstein, D. I., “Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.”, Vaccine, vol. 36, no. 6, pp. 881-889, 2018.
C
L. E. Widdice, Hoagland, R., S Callahan, T., Kahn, J. A., Harrison, C. J., Pahud, B. A., Frey, S. E., Berry, A. A., Kotloff, K. L., Edwards, K. M., Mulligan, M. J., Sudman, J., Nakamura, A., and Bernstein, D. I., “Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.”, Vaccine, vol. 36, no. 11, pp. 1491-1499, 2018.
R. B. Belshe, Heineman, T. C., Bernstein, D. I., Bellamy, A. R., Ewell, M., van der Most, R., and Deal, C. D., “Correlate of immune protection against HSV-1 genital disease in vaccinated women.”, J Infect Dis, vol. 209, no. 6, pp. 828-36, 2014.
S. A. Ross, Pati, P., Jensen, T. L., Goll, J. B., Gelber, C. E., Singh, A., McNeal, M., Boppana, S. B., and Bernstein, D. I., “Cytomegalovirus Genetic Diversity Following Primary Infection.”, J Infect Dis, vol. 221, no. 5, pp. 715-720, 2020.
D
J. E. Ledgerwood, Bellamy, A. R., Belshe, R., Bernstein, D. I., Edupuganti, S., Patel, S. M., Renehan, P., Zajdowicz, T., Schwartz, R., Koup, R., Bailer, R. T., Yamshchikov, G. V., Enama, M. E., Sarwar, U., Larkin, B., and Graham, B. S., “DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial.”, PLoS One, vol. 10, no. 5, p. e0125914, 2015.
K. V. Houser, Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Paskel, M., Subbarao, K., Anderson, E., Bernstein, D. I., Creech, B., Keyserling, H., Spearman, P., Wright, P. F., Graham, B. S., and Ledgerwood, J. E., “DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.”, PLoS One, vol. 13, no. 11, p. e0206837, 2018.
E
D. I. Bernstein, Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. K. B., Graham, I. L., Noah, D. L., He, F., and Hill, H., “Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.”, J Infect Dis, vol. 197, no. 5, pp. 667-75, 2008.
R. B. Belshe, Leone, P. A., Bernstein, D. I., Wald, A., Levin, M. J., Stapleton, J. T., Gorfinkel, I., Morrow, R. L. Ashley, Ewell, M. G., Stokes-Riner, A., Dubin, G., Heineman, T. C., Schulte, J. M., and Deal, C. D., “Efficacy results of a trial of a herpes simplex vaccine.”, N Engl J Med, vol. 366, no. 1, pp. 34-43, 2012.
D. I. Bernstein, Bellamy, A. R., Hook, E. W., Levin, M. J., Wald, A., Ewell, M. G., Wolff, P. A., Deal, C. D., Heineman, T. C., Dubin, G., and Belshe, R. B., “Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.”, Clin Infect Dis, vol. 56, no. 3, pp. 344-51, 2013.
H
J. M. Schulte, Bellamy, A. R., Hook, E. W., Bernstein, D. I., Levin, M. J., Leone, P. A., Sokol-Anderson, M. L., Ewell, M. G., Wolff, P. A., Heineman, T. C., and Belshe, R. B., “HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).”, South Med J, vol. 107, no. 2, pp. 79-84, 2014.
I
P. Winokur, Sahly, H. M. El, Mulligan, M. J., Frey, S. E., Rupp, R., Anderson, E. J., Edwards, K. M., Bernstein, D. I., Schmader, K., Jackson, L. A., Chen, W. H., Hill, H., and Bellamy, A., “Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.”, Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
D. I. Bernstein, Jackson, L., Patel, S. M., Sahly, H. M. El, Spearman, P., Rouphael, N., Rudge, T. L., Hill, H., and Goll, J. B., “Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults.”, Vaccine, vol. 32, no. 47, pp. 6284-93, 2014.
M
K. L. Kotloff, Shirley, D. - A. T., C Creech, B., Frey, S. E., Harrison, C. J., Staat, M., Anderson, E. J., Dulkerian, S., Thomsen, I. P., Al-Hosni, M., Pahud, B. A., Bernstein, D. I., Yi, J., Petrikin, J. E., Haberman, B., Stephens, K., Stephens, I., Oler, R. E., and Conrad, T. M., “Mupirocin for Decolonization of Infants in Neonatal Intensive Care Units.”, Pediatrics, vol. 143, no. 1, 2019.
N
D. I. Bernstein, Atmar, R. L., G Lyon, M., Treanor, J. J., Chen, W. H., Jiang, X., Vinjé, J., Gregoricus, N., Frenck, R. W., Moe, C. L., Al-Ibrahim, M. S., Barrett, J., Ferreira, J., Estes, M. K., Graham, D. Y., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., “Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.”, J Infect Dis, vol. 211, no. 6, pp. 870-8, 2015.
R. L. Atmar, Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., and Mendelman, P. M., “Norovirus vaccine against experimental human Norwalk Virus illness.”, N Engl J Med, vol. 365, no. 23, pp. 2178-87, 2011.
P
D. I. Bernstein, Pasetti, M. F., Brady, R., Buskirk, A. D., Wahid, R., Dickey, M., Cohen, M., Baughman, H., El-Khorazaty, J., Maier, N., Sztein, M. B., Baqar, S., and A Bourgeois, L., “A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.”, Vaccine, vol. 37, no. 4, pp. 602-611, 2019.
T. C. Heineman, Schleiss, M., Bernstein, D. I., Spaete, R. R., Yan, L., Duke, G., Prichard, M., Wang, Z., Yan, Q., Sharp, M. A., Klein, N., Arvin, A. M., and Kemble, G., “A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.”, J Infect Dis, vol. 193, no. 10, pp. 1350-60, 2006.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. El, Rouphael, N. Georges, Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., “Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.”, Vaccine, vol. 33, no. 1, pp. 163-73, 2015.
R
R. C. Brady, Jackson, L. A., Frey, S. E., Shane, A. L., Walter, E. B., Swamy, G. K., Schlaudecker, E. P., Szefer, E., Wolff, M., McNeal, M. Malone, Bernstein, D. I., and Steinhoff, M. C., “Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.”, Vaccine, vol. 36, no. 31, pp. 4663-4671, 2018.
S
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., “Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.”, J Infect Dis, vol. 206, no. 6, pp. 828-37, 2012.
D. I. Bernstein, Sahly, H. M. El, Keitel, W. A., Wolff, M., Simone, G., Segawa, C., Wong, S., Shelly, D., Young, N. S., and Dempsey, W., “Safety and immunogenicity of a candidate parvovirus B19 vaccine.”, Vaccine, vol. 29, no. 43, pp. 7357-63, 2011.
P. L. Winokur, Hegmann, T. E., Keitel, W. A., Bernstein, D. I., Frey, S. E., and Bryant, C., “Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults.”, Clin Infect Dis, 2023.
F. Scaggs Huang, Bernstein, D. I., Slobod, K. S., Portner, A., Takimoto, T., Russell, C. J., Meagher, M., Jones, B. G., Sealy, R. E., Coleclough, C., Branum, K., Dickey, M., Buschle, K., McNeal, M., Makowski, M., Nakamura, A., and Hurwitz, J. L., “Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults.”, Hum Vaccin Immunother, vol. 17, no. 2, pp. 554-559, 2021.
N. B. Halasa, Gerber, M. A., Berry, A. A., Anderson, E. L., Winokur, P., Keyserling, H., Eckard, A. Ross, Hill, H., Wolff, M. C., McNeal, M. M., Edwards, K. M., and Bernstein, D. I., “Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.”, J Pediatric Infect Dis Soc, vol. 4, no. 3, pp. 214-24, 2015.